U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06896708) titled 'Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients with Chronic Coronary Syndrome' on Feb. 11.

Brief Summary: This is a multicenter, open-label, parallel-group, randomized trial to determine if intensive lipid-lowering therapy (goal for LDL-C =50% reduction frome baseline) could delay progression of coronary atherosclerotic obstructive leisions compared with guideline recommended lipid-lowering therapy (goal for LDL-C =50% reduction frome baseline) among participants between 18-60 years old with non-invasively managed chronic coronary syndrome (at least one le...